Human osteosarcoma cells respond to sorafenib chemotherapy by downregulation of the tumor progression factors S100A4, CXCR4 and the oncogene FOS

Author：              

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.31, Iss.3, 2014-01, pp. : 1147-1156

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Downregulation of S100A4 expression by RNA interference suppresses cell growth and invasion in human colorectal cancer cells

By Huang Liyong   Xu Ye   Cai Guoxiang   Guan Zuqing   Cai Sanjun  

Oncology Reports, Vol. 27, Iss. 4, 2012-04 ,pp. : 917-922

Spandidos Publications

Access to resources Recommend Favorite

Downregulation of UHRF1 promotes EMT via inducing CXCR4 in human cancer cells

By  

International Journal of Oncology, Vol. 46, Iss. 3, 2015-03 ,pp. : 1232-1242

Spandidos Publications

Access to resources Recommend Favorite

S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells

By Mathisen Berit   Lindstad Rune   Hansen Janne   El-Gewely Sara   Maelandsmo Gunhild   Hovig Eivind   Fodstad Øystein   Loennechen Thrina   Winberg Jan-Olof  

Clinical and Experimental Metastasis, Vol. 20, Iss. 8, 2003-12 ,pp. : 701-711

Springer Publishing Company

Access to resources Recommend Favorite

Stable knockdown of S100A4 suppresses cell migration and metastasis of osteosarcoma

By Fujiwara Masahiko  

Tumor Biology, Vol. 32, Iss. 3, 2011-06 ,pp. : 611-622

Springer Publishing Company

Access to resources Recommend Favorite

The clinical value of CXCR4, HER2 and CD44 in human osteosarcoma: A pilot study

By                

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 797-801

Spandidos Publications

Access to resources Recommend Favorite